J Pediatr Hematol Oncol 37:e162e169 Porter J, Taher A, Mufarrij A, Gavalas M (2012) In: Eleftheriou A, Angastiniotis M, Telfer P (eds) Emergency management of thalassaemia
The Phase 3 OPTIONS study (536 subjects, 24 weeks) failed to show statistically significant weight loss compared to placebo
Recalls & Warnings April 14, 2026 Bari Life, Bird&Be, Dr
If the J-code unit billed doesnt match the administered dose documented in the chart, expect a post-payment audit recovery request
UK clinical practice, guided by the Specialist Pharmacy Service, generally discourages routine multi-dose vial use, and any diluent should be sourced from a reputable pharmaceutical-grade supplier